US$ 23.71
tirzepatide pediatric Big update in diabetes care 🩺 Mounjaro® (tirzepatide) is now FDA-approved for children ≥10 years old with Type 2 diabetes as an adjunct to diet and exercise. What this means ⬇️ Zepbound Now Available Through LillyDirect:
Description
All orders have been seamless

This reverse check is worth doing every time, especially when starting a new vial or adjusting doses

Interestingly, the SURMOUNT-5 trial found that gastrointestinal adverse events causing treatment discontinuation occurred in 5.6% of semaglutide users compared to only 2.7% of tirzepatide users

This does not predict your final outcome